Aranidipine is a novel dihydropyridine derivative that gives rise to two active metabolites (M-1α and M-1β) that exhibit hypotensive activity. It is a calcium antagonist with the formula methyl 2-oxopropyl 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridinedicarboxylate. It was developed by Maruko Seiyaku, introduced by Taiho and launched in Japan in 1997. It is grouped under the following drug class(es): Calcium Channel Blockers and Vasodilating agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Sapresta and aranidipinum. Its PubChem CID is 2225.
Aranidipine
| CAS No | 86780-90-7 |
|---|---|
| Molecular Formula | C19H20N2O7 |
| Molecular Weight | 388.40 g/mol |
| Synonyms | 3-O-methyl 5-O-(2-oxopropyl) 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Aranidipine is a novel dihydropyridine derivative that gives rise to two active metabolites (M-1α and M-1β) that exhibit hypotensive activity. It is a calcium antagonist with the formula methyl 2-oxopropyl 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridinedicarboxylate.
The listed CAS number is 86780-90-7.
The listed molecular formula is C19H20N2O7.
The listed molecular weight is 388.40 g/mol.
3-O-methyl 5-O-(2-oxopropyl) 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate.
The source lists Sapresta and aranidipinum.